** COVID-19: ECHM-EUBS Position Statement on the use of HBOT for treatment of COVID-19 patients

In response to the current and ongoing COVID-19 (SARS-CoV-2) pandemic, the European Committee for Hyperbaric Medicine (ECHM) and EUBS have issued a new Position Statement on the use of HBOT as a treatment for COVID-19 patients. This Statement complements our previous Position Statement on “Hyperbaric Oxygen Therapy (HBOT) in multiplace hyperbaric chambers during coronavirus disease (COVID-19) outbreak”, which remains fully valid.

Please download and read the attached document. The original document is in English, but translated versions, thanks to our community, are available below and on the ECHM website (www.echm.org).

Let us face this unprecedented challenge, together, in concerted action, and take the necessary measures to protect our patients and (para)medical personnel.

English: ECHM-EUBS position on the use of HBOT for COVID-19 (1st May 2020)
Italian: ECHM-EUBS position on the use of HBOT for COVID-19 (1st May 2020)
French: Position de l’ECHM-EUBS sur l’OHB chez des patients COVID-19 (1er Mai 2020)
Portuguese: ECHM EUBS position on the use of HBOT for COVID-19 (1st May 2020)
Greek: ECHM-EUBS position on the use of HBOT for COVID-19 (1st May 2020)
Turkish: ECHM-EUBS position on the use of HBOT for COVID-19 (1st May 2020)
Spanish: ECHM-EUBS Posicion sobre uso de OHB para COVID-19 (1 Mayo 2020)
Polish: ECHM-EUBS position on the use of HBOT for COVID-19 (1st May 2020)

Leave a Reply

Your email address will not be published. Required fields are marked *